Analyst Research Report Snapshot

Title:

Celsion (CLSN) Coverage Updated by Griffin Securities

Price:

$46.00

Provider:

Griffin Securities, Inc.

Date:

22 Jan 2013

Pages:

6

Type:

AcrobatPDF

Companies referenced:

CLSN.OQ

Available for Immediate Download
Summary:

Celsion Corporation (NasdaqCM: CLSN) expands its relationship with Hisun Pharmaceutical to include distribution of ThermoDox in China, Hong Kong, and Macau. Deal terms are quite favorable, with $100 million in upfront and milestone payments and escalating double-digit royalties. Data from the HEAT Study is expected to be announced shortly.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.